Main Research Field
Home Main Research Field
Innovative and minimally invasive blood vessel generation technology
Innovative and Minimally Invasive Blood Vessel Generation Technology
This technology
indirectly induces revascularization and angiogenesis in patients with cerebral blood flow disorders such as Moyamoya disease.
It is minimally invasive when compared to other techniques and can create healthier blood vessels through combination with medication.
Academic paper
- Hong et al., 2022, Stroke, Transdural Revascularization by Multiple Burrhole After Erythropoietin in Stroke Patients With Cerebral Hypoperfusion: A Randomized
Controlled Trial. - Park et al., 2020, Neurobiology of diasease, Cranial burr hole with erythropoietin administration induces reverse arteriogenesis from the enriched extracranium
- Hong et al., 2018, Stroke, Feasibility of multiple Burr hole with erythropoietin in acute Moyamoya patients.
Clinical Trial
- ClinicalTrials.gov Identifier: NCT02603406
- Neovascularization Induced by Mechanical Barrier disrUption and Systemic Erythropoietin in Patients With Cerebral Perfusion Deficits (NIMBUS)